Table 3

Patient’s characteristics, valve dysfunction, aortic diameters and dilation according to the presence of raphe

Variable No raphe
n=144
(18.8%)
Raphe
n=644
(81.2%)
p Value
Demographics and clinical data
 Age, years46.2±17.247.6±16.70.32
 Female, n (%)93 (65)465 (72)0.08
 BSA, kg/m2 1.83±0.221.85±0.190.50
 Smoker, n (%)16 (11.8)91 (14.4)0.496
 Hypertension, n (%)50 (36.5)201 (31.5)0.269
Valve dysfunction
 Non-significant, n (%)94 (65.3)314 (48.7)0.001
 AS dominant, n (%)16 (11.1)166 (25.8)
 AR dominant, n (%)34 (23.6)164 (25.4)
Aortic diameter
 Aortic annulus, mm23.6±3.323.2±3.30.174
 Aortic root, mm37.1±6.336.8±5.60.515
 STJ, mm31.1±6.030.4±6.50.071
 Ascending aorta, mm40.6±7.141.1±7.60.652
 Aortic arch, mm30.1±5.5531.7±5.50.238
Aortic dilation
 Non-dilation, n (%)22 (15.3)121 (18.8)0.341
 Root dilation, n (%)60 (41.7)214 (33.2)0.066
 Ascending aorta dilation, n (%)116 (81.1)498 (77.6)0.373
  • AR, aortic regurgitation; AS, aortic stenosis; BSA, body surface area; STJ, sinotubular junction.